The graphs depict the results of a survey conducted in an expansive rural community in June 1996. The survey focused on females—receiving new vaccine groups most at risk—and included relevant activity information, such as the number of flu deaths and flu rates among people in the year.
The first graph shows a rise in influenza death count for both genders, with females experiencing a higher figure mortality than males. From March to May, female flu mortality quadrupled from one to four between June and August, while male fatalities doubled to two over the same period.
The second graph reveals the detailed ratio of the distribution of vaccine recipients, focusing only on the female recipient groups at most risk. Of those vaccine recipients, 35% were elderly women, 24% were infants or children, and 13% were hospitalized. However, 28% did not participate in the trial.
Moving to the third graph, both women and men showed a similar trend, with women consistently having more flu cases. Female cases peaked at 3,500 in June before declining to 2,500 by year-end.
In conclusion, the vaccine appears to have reduced flu deaths and cases, particularly among women, highlighting its potential effectiveness.